Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis

IntroductionMeasurable residual disease (MRD)-directed interferon-a treatment (i.e. preemptive IFN-α treatment) can eliminate the MRD in patients with acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Therefore, this study aimed to further assess its...

Полное описание

Библиографические подробности

Главные авторы:	Shuang Fan, Tian-Zhong Pan, Li-Ping Dou, Yan-Min Zhao, Xiao-Hui Zhang, Lan-Ping Xu, Yu Wang, Xiao-Jun Huang, Xiao-Dong Mo
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Frontiers Media S.A. 2023-02-01
Серии:	Frontiers in Immunology
Предметы:	interferon-α acute myeloid leukemia hematopoietic stem cell transplantation measurable residual disease preemptive
Online-ссылка:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1091014/full
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!